Skip to content

Clinical trials

Phase 3 Genetic Diseases, Inborn trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Phase: Phase 3 Country / region: Belgium Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20172
20182
20212
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated3
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
PTC Therapeutics2
Quince Therapeutics S.p.A.2
Avidity Biosciences, Inc.1
BioMarin Pharmaceutical1
Kyntra Bio1
Pfizer1
Vertex Pharmaceuticals Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn9
Nervous System Diseases5
Muscular Diseases4
Muscular Disorders, Atrophic4
Muscular Dystrophies4
Muscular Dystrophy, Duchenne4
Musculoskeletal Diseases4
Neuromuscular Diseases4
Genetic Diseases, X-Linked3
Hematologic Diseases2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.